Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Shp-1 (human), (recombinant)

BML-SE334-0020 20 µg 446.00 USD
Do you need bulk/larger quantities?

Product Details

Alternative Name:Src homology-2 containing protein tyrosine phosphatase 1
MW:67.5 kDa
Source:Produced in E. coli. Full length human Shp-1 (aa 1-595).
UniProt ID:P29350
Formulation:Liquid. In 50mM TRIS/HCl, pH 8.0, containing 150mM NaCl, 5mM DTT, 0.03% Brij 35, 0.1mM EDTA and 10% glycerol.
Purity:≥90% (SDS-PAGE)
Purity Detail:Purified by multi-step chromatography.
Specific Activity:≥2000 pmol/min/µg assayed by p-nitrophenylphosphate (pNPP, 50 mM) hydrolysis at pH 7.0, 30°C
Shipping:Shipped on Dry Ice
Long Term Storage:-80°C
Scientific Background:Shp-1 is one of two human “Src Homology-2 (SH2) containing phosphatases”, enzymes in which two regulatory phosphotyrosine binding domains (N-SH2 & C-SH2) lie N-terminal to the catalytic (PTP) domain. Recruitment of Shp-1 (Src Homology-2 (SH2) containing phosphatase-1) to cell-surface receptors is mediated by SH2-domain binding to “Immuno-receptor Tyrosine-based Inhibitory Motifs” (consensus ITIM: [I/V/L]-x-pY-x-x-[I/V/L]; death receptor variant: A-x-pY-x-x-L). This binding activates Shp-1 phosphatase by displacing an inhibitory interaction between the N-SH2 and PTP domains. By dephosphorylating the downstream elements of various signal transduction pathways, Shp-1 acts as a negative regulator. Shp-1 is highly expressed in hematopoietic cells and to a lesser extent in epithelial cells. It plays a significant role in various stages of hematopoietic development and in limiting neutrophil activation and inflammatory tissue damage through down-regulation of anti-apoptotic, cytokine-derived signals. In most lymphomas and leukemias Shp-1 expression is decreased or absent and Shp-1 may play a role in the pathogenesis of these and other cancers.
Regulatory Status:RUO - Research Use Only
Shp-1 (human), (recombinant) SDS-PAGE
SDS-PAGE analysis: Lane 1: MW Marker; Lane 2: 2.0μg of purified Shp-1 (human) (recombinant).
Please mouse over
Shp-1 (human), (recombinant) SDS-PAGE

Product Literature References

The myeloperoxidase-derived oxidant hypothiocyanous acid inhibits protein tyrosine phosphatases via oxidation of key cysteine residues: N.L. Cook, et al.; Free Radic. Biol. Med. 90, 195 (2016), Abstract;
Syntheses and activities of backbone-side chain cyclic octapeptide ligands with N-functionalized phosphotyrosine for the N-terminal SH2-domain of the protein tyrosine phosphatase SHP-1: M.S. Zoda, et al.; J. Pept. Sci. 16, 403 (2010), Abstract;

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
PTP Recombinant protein
PTP Enzyme
By catalog section:


Technical Service
Customer Service

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

All new literature pieces

Recommend this page

Keep in touch

©2021 Enzo Life Sciences, Inc.,